BR112013025500A2 - método para detectar contaminantes pró-inflamatórios de polímeros de glicose - Google Patents

método para detectar contaminantes pró-inflamatórios de polímeros de glicose

Info

Publication number
BR112013025500A2
BR112013025500A2 BR112013025500A BR112013025500A BR112013025500A2 BR 112013025500 A2 BR112013025500 A2 BR 112013025500A2 BR 112013025500 A BR112013025500 A BR 112013025500A BR 112013025500 A BR112013025500 A BR 112013025500A BR 112013025500 A2 BR112013025500 A2 BR 112013025500A2
Authority
BR
Brazil
Prior art keywords
proinflammatory
contaminants
detecting
glucose polymers
glucose
Prior art date
Application number
BR112013025500A
Other languages
English (en)
Other versions
BR112013025500B8 (pt
BR112013025500B1 (pt
Inventor
Denys Agnés
Allain Fabrice
Hacine-Gherbi Héla
Carpentier Mathieu
Lanos Pierre
Original Assignee
Roquette Freres
Priority date (The priority date is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the date listed.)
Filing date
Publication date
Family has litigation
First worldwide family litigation filed litigation Critical https://patents.darts-ip.com/?family=46062619&utm_source=google_patent&utm_medium=platform_link&utm_campaign=public_patent_search&patent=BR112013025500(A2) "Global patent litigation dataset” by Darts-ip is licensed under a Creative Commons Attribution 4.0 International License.
Priority claimed from FR1157073A external-priority patent/FR2978774B1/fr
Application filed by Roquette Freres filed Critical Roquette Freres
Publication of BR112013025500A2 publication Critical patent/BR112013025500A2/pt
Publication of BR112013025500B1 publication Critical patent/BR112013025500B1/pt
Publication of BR112013025500B8 publication Critical patent/BR112013025500B8/pt

Links

Classifications

    • CCHEMISTRY; METALLURGY
    • C12BIOCHEMISTRY; BEER; SPIRITS; WINE; VINEGAR; MICROBIOLOGY; ENZYMOLOGY; MUTATION OR GENETIC ENGINEERING
    • C12QMEASURING OR TESTING PROCESSES INVOLVING ENZYMES, NUCLEIC ACIDS OR MICROORGANISMS; COMPOSITIONS OR TEST PAPERS THEREFOR; PROCESSES OF PREPARING SUCH COMPOSITIONS; CONDITION-RESPONSIVE CONTROL IN MICROBIOLOGICAL OR ENZYMOLOGICAL PROCESSES
    • C12Q1/00Measuring or testing processes involving enzymes, nucleic acids or microorganisms; Compositions therefor; Processes of preparing such compositions
    • C12Q1/02Measuring or testing processes involving enzymes, nucleic acids or microorganisms; Compositions therefor; Processes of preparing such compositions involving viable microorganisms
    • GPHYSICS
    • G01MEASURING; TESTING
    • G01NINVESTIGATING OR ANALYSING MATERIALS BY DETERMINING THEIR CHEMICAL OR PHYSICAL PROPERTIES
    • G01N33/00Investigating or analysing materials by specific methods not covered by groups G01N1/00 - G01N31/00
    • G01N33/48Biological material, e.g. blood, urine; Haemocytometers
    • G01N33/50Chemical analysis of biological material, e.g. blood, urine; Testing involving biospecific ligand binding methods; Immunological testing
    • G01N33/5005Chemical analysis of biological material, e.g. blood, urine; Testing involving biospecific ligand binding methods; Immunological testing involving human or animal cells
    • G01N33/5008Chemical analysis of biological material, e.g. blood, urine; Testing involving biospecific ligand binding methods; Immunological testing involving human or animal cells for testing or evaluating the effect of chemical or biological compounds, e.g. drugs, cosmetics
    • G01N33/5044Chemical analysis of biological material, e.g. blood, urine; Testing involving biospecific ligand binding methods; Immunological testing involving human or animal cells for testing or evaluating the effect of chemical or biological compounds, e.g. drugs, cosmetics involving specific cell types
    • G01N33/5047Cells of the immune system
    • G01N33/5055Cells of the immune system involving macrophages
    • AHUMAN NECESSITIES
    • A61MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61PSPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P7/00Drugs for disorders of the blood or the extracellular fluid
    • A61P7/08Plasma substitutes; Perfusion solutions; Dialytics or haemodialytics; Drugs for electrolytic or acid-base disorders, e.g. hypovolemic shock
    • CCHEMISTRY; METALLURGY
    • C12BIOCHEMISTRY; BEER; SPIRITS; WINE; VINEGAR; MICROBIOLOGY; ENZYMOLOGY; MUTATION OR GENETIC ENGINEERING
    • C12QMEASURING OR TESTING PROCESSES INVOLVING ENZYMES, NUCLEIC ACIDS OR MICROORGANISMS; COMPOSITIONS OR TEST PAPERS THEREFOR; PROCESSES OF PREPARING SUCH COMPOSITIONS; CONDITION-RESPONSIVE CONTROL IN MICROBIOLOGICAL OR ENZYMOLOGICAL PROCESSES
    • C12Q1/00Measuring or testing processes involving enzymes, nucleic acids or microorganisms; Compositions therefor; Processes of preparing such compositions
    • C12Q1/02Measuring or testing processes involving enzymes, nucleic acids or microorganisms; Compositions therefor; Processes of preparing such compositions involving viable microorganisms
    • C12Q1/22Testing for sterility conditions
    • CCHEMISTRY; METALLURGY
    • C12BIOCHEMISTRY; BEER; SPIRITS; WINE; VINEGAR; MICROBIOLOGY; ENZYMOLOGY; MUTATION OR GENETIC ENGINEERING
    • C12QMEASURING OR TESTING PROCESSES INVOLVING ENZYMES, NUCLEIC ACIDS OR MICROORGANISMS; COMPOSITIONS OR TEST PAPERS THEREFOR; PROCESSES OF PREPARING SUCH COMPOSITIONS; CONDITION-RESPONSIVE CONTROL IN MICROBIOLOGICAL OR ENZYMOLOGICAL PROCESSES
    • C12Q1/00Measuring or testing processes involving enzymes, nucleic acids or microorganisms; Compositions therefor; Processes of preparing such compositions
    • C12Q1/34Measuring or testing processes involving enzymes, nucleic acids or microorganisms; Compositions therefor; Processes of preparing such compositions involving hydrolase
    • C12Q1/42Measuring or testing processes involving enzymes, nucleic acids or microorganisms; Compositions therefor; Processes of preparing such compositions involving hydrolase involving phosphatase
    • CCHEMISTRY; METALLURGY
    • C12BIOCHEMISTRY; BEER; SPIRITS; WINE; VINEGAR; MICROBIOLOGY; ENZYMOLOGY; MUTATION OR GENETIC ENGINEERING
    • C12QMEASURING OR TESTING PROCESSES INVOLVING ENZYMES, NUCLEIC ACIDS OR MICROORGANISMS; COMPOSITIONS OR TEST PAPERS THEREFOR; PROCESSES OF PREPARING SUCH COMPOSITIONS; CONDITION-RESPONSIVE CONTROL IN MICROBIOLOGICAL OR ENZYMOLOGICAL PROCESSES
    • C12Q1/00Measuring or testing processes involving enzymes, nucleic acids or microorganisms; Compositions therefor; Processes of preparing such compositions
    • C12Q1/68Measuring or testing processes involving enzymes, nucleic acids or microorganisms; Compositions therefor; Processes of preparing such compositions involving nucleic acids
    • C12Q1/6897Measuring or testing processes involving enzymes, nucleic acids or microorganisms; Compositions therefor; Processes of preparing such compositions involving nucleic acids involving reporter genes operably linked to promoters
    • GPHYSICS
    • G01MEASURING; TESTING
    • G01NINVESTIGATING OR ANALYSING MATERIALS BY DETERMINING THEIR CHEMICAL OR PHYSICAL PROPERTIES
    • G01N33/00Investigating or analysing materials by specific methods not covered by groups G01N1/00 - G01N31/00
    • G01N33/15Medicinal preparations ; Physical properties thereof, e.g. dissolubility
    • GPHYSICS
    • G01MEASURING; TESTING
    • G01NINVESTIGATING OR ANALYSING MATERIALS BY DETERMINING THEIR CHEMICAL OR PHYSICAL PROPERTIES
    • G01N33/00Investigating or analysing materials by specific methods not covered by groups G01N1/00 - G01N31/00
    • G01N33/48Biological material, e.g. blood, urine; Haemocytometers
    • G01N33/50Chemical analysis of biological material, e.g. blood, urine; Testing involving biospecific ligand binding methods; Immunological testing
    • G01N33/5005Chemical analysis of biological material, e.g. blood, urine; Testing involving biospecific ligand binding methods; Immunological testing involving human or animal cells
    • GPHYSICS
    • G01MEASURING; TESTING
    • G01NINVESTIGATING OR ANALYSING MATERIALS BY DETERMINING THEIR CHEMICAL OR PHYSICAL PROPERTIES
    • G01N33/00Investigating or analysing materials by specific methods not covered by groups G01N1/00 - G01N31/00
    • G01N33/48Biological material, e.g. blood, urine; Haemocytometers
    • G01N33/50Chemical analysis of biological material, e.g. blood, urine; Testing involving biospecific ligand binding methods; Immunological testing
    • G01N33/5005Chemical analysis of biological material, e.g. blood, urine; Testing involving biospecific ligand binding methods; Immunological testing involving human or animal cells
    • G01N33/5008Chemical analysis of biological material, e.g. blood, urine; Testing involving biospecific ligand binding methods; Immunological testing involving human or animal cells for testing or evaluating the effect of chemical or biological compounds, e.g. drugs, cosmetics
    • G01N33/5044Chemical analysis of biological material, e.g. blood, urine; Testing involving biospecific ligand binding methods; Immunological testing involving human or animal cells for testing or evaluating the effect of chemical or biological compounds, e.g. drugs, cosmetics involving specific cell types
    • G01N33/5047Cells of the immune system
    • AHUMAN NECESSITIES
    • A61MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61PSPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P3/00Drugs for disorders of the metabolism
    • A61P3/02Nutrients, e.g. vitamins, minerals

Landscapes

  • Health & Medical Sciences (AREA)
  • Life Sciences & Earth Sciences (AREA)
  • Chemical & Material Sciences (AREA)
  • Engineering & Computer Science (AREA)
  • Immunology (AREA)
  • Organic Chemistry (AREA)
  • Molecular Biology (AREA)
  • General Health & Medical Sciences (AREA)
  • Biomedical Technology (AREA)
  • Bioinformatics & Cheminformatics (AREA)
  • Hematology (AREA)
  • Wood Science & Technology (AREA)
  • Proteomics, Peptides & Aminoacids (AREA)
  • Zoology (AREA)
  • Analytical Chemistry (AREA)
  • Biochemistry (AREA)
  • Physics & Mathematics (AREA)
  • Microbiology (AREA)
  • Biotechnology (AREA)
  • Urology & Nephrology (AREA)
  • Cell Biology (AREA)
  • Medicinal Chemistry (AREA)
  • Genetics & Genomics (AREA)
  • Biophysics (AREA)
  • General Engineering & Computer Science (AREA)
  • Food Science & Technology (AREA)
  • General Physics & Mathematics (AREA)
  • Pathology (AREA)
  • Public Health (AREA)
  • Tropical Medicine & Parasitology (AREA)
  • Toxicology (AREA)
  • Pharmacology & Pharmacy (AREA)
  • Epidemiology (AREA)
  • Chemical Kinetics & Catalysis (AREA)
  • General Chemical & Material Sciences (AREA)
  • Nuclear Medicine, Radiotherapy & Molecular Imaging (AREA)
  • Diabetes (AREA)
  • Animal Behavior & Ethology (AREA)
  • Veterinary Medicine (AREA)
  • Nutrition Science (AREA)
BR112013025500A 2011-04-08 2012-04-06 método para detectar contaminação por peptídoglicanos (pgn) de polímeros de glicose BR112013025500B8 (pt)

Applications Claiming Priority (9)

Application Number Priority Date Filing Date Title
FR1153050 2011-04-08
FR1153050 2011-04-08
FR1154342 2011-05-19
FR1154342 2011-05-19
FR1157073 2011-08-02
FR1157073A FR2978774B1 (fr) 2011-08-02 2011-08-02 Methodes de detection des contaminants des circuits de production de polymeres de glucose
FR1160921 2011-11-29
FR1160921 2011-11-29
PCT/FR2012/050755 WO2012143647A1 (fr) 2011-04-08 2012-04-06 Méthodes de détection de contaminants dans des solutions contenants des polymères de glucose

Publications (3)

Publication Number Publication Date
BR112013025500A2 true BR112013025500A2 (pt) 2017-11-14
BR112013025500B1 BR112013025500B1 (pt) 2021-02-02
BR112013025500B8 BR112013025500B8 (pt) 2021-04-06

Family

ID=46062619

Family Applications (1)

Application Number Title Priority Date Filing Date
BR112013025500A BR112013025500B8 (pt) 2011-04-08 2012-04-06 método para detectar contaminação por peptídoglicanos (pgn) de polímeros de glicose

Country Status (12)

Country Link
US (2) US9494576B2 (pt)
EP (2) EP3495816A1 (pt)
JP (2) JP5989088B2 (pt)
KR (1) KR101918790B1 (pt)
CN (1) CN103492878B (pt)
AU (1) AU2012246182B2 (pt)
BR (1) BR112013025500B8 (pt)
CA (2) CA3077116C (pt)
MX (1) MX350641B (pt)
RU (1) RU2557995C2 (pt)
SG (2) SG10201602761TA (pt)
WO (1) WO2012143647A1 (pt)

Families Citing this family (7)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
JP5989088B2 (ja) * 2011-04-08 2016-09-07 ロケット フレールRoquette Freres グルコースポリマーに含まれる汚染物質の検出方法
CA2873376C (fr) * 2012-05-29 2022-04-19 Roquette Freres Methodes de decontamination des circuits de production de polymeres de glucose et d'hydrolysats de polymeres de glucose
WO2014154651A1 (fr) * 2013-03-26 2014-10-02 Roquette Freres Dosage biologique des peptidoglycanes
MX2016009774A (es) 2014-02-07 2016-11-14 Roquette Freres Ensayo biologico de peptidoglicanos.
US20170081688A1 (en) * 2014-03-21 2017-03-23 Roquette Freres Optimized method for decontaminating production of glucose polymers and glucose polymer hydrolyzates
KR20160066372A (ko) * 2014-12-02 2016-06-10 (주)바텍이우홀딩스 엑스선 센서용 인터페이스 장치와 이를 포함한 엑스선 센서 모듈
FR3037063B1 (fr) 2015-06-04 2017-05-19 Roquette Freres Procede optimise de decontamination de l'amidon utilise comme matiere premiere pour l'obtention de polymeres de glucose destines a la dialyse peritoneale

Family Cites Families (11)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
DE3689863T2 (de) 1985-06-22 1995-01-05 Ml Lab Plc In kontinuierlicher Peritonealdialyse verwendete Polymere.
FR2716199B1 (fr) 1994-02-15 1996-04-26 Roquette Freres Procédé de fabrication d'un hydrolysat d'amidon à faible indice de polymolécularité, nouvel hydrolysat d'amidon ainsi obtenu et son utilisation en dialyse péritonéale.
WO2004094671A2 (en) 2003-04-22 2004-11-04 Coley Pharmaceutical Gmbh Methods and products for identification and assessment of tlr ligands
DK2360479T3 (da) * 2005-12-22 2014-04-07 Baxter Int Forbedret monocytaktiveringsprøve til påvisning af pyrogene ikke-endotoxin-forureninger i medicinske produkter
DE102006031483B4 (de) * 2006-07-07 2009-12-24 Fraunhofer-Gesellschaft zur Förderung der angewandten Forschung e.V. Zellulärer Pyrogentest
US20090317838A1 (en) 2008-03-17 2009-12-24 Jean-Marc Cavaillion Detection of bacterial peptidoglycan-like compounds
US20090239819A1 (en) 2008-03-20 2009-09-24 Run Wang Peritoneal dialysis solution test method
US20090239238A1 (en) * 2008-03-20 2009-09-24 Baxter International Inc. Methods for measuring pro-inflammatory substance levels in dialysis solutions and dialysis components
FR2945043B1 (fr) 2009-04-30 2019-07-26 Roquette Freres Procede de purification de polymeres de glucose destines aux solutions de dialyse peritoneale
JP5989088B2 (ja) * 2011-04-08 2016-09-07 ロケット フレールRoquette Freres グルコースポリマーに含まれる汚染物質の検出方法
WO2014154651A1 (fr) * 2013-03-26 2014-10-02 Roquette Freres Dosage biologique des peptidoglycanes

Also Published As

Publication number Publication date
JP5989088B2 (ja) 2016-09-07
MX350641B (es) 2017-09-11
MX2013011547A (es) 2014-02-28
SG10201602761TA (en) 2016-05-30
JP2014510924A (ja) 2014-05-01
EP2694961B1 (fr) 2019-01-02
SG194005A1 (en) 2013-11-29
US9494576B2 (en) 2016-11-15
RU2557995C2 (ru) 2015-07-27
CN103492878B (zh) 2015-11-25
AU2012246182A1 (en) 2013-10-31
BR112013025500B8 (pt) 2021-04-06
BR112013025500B1 (pt) 2021-02-02
CN103492878A (zh) 2014-01-01
CA3077116C (fr) 2022-07-19
EP2694961A1 (fr) 2014-02-12
JP2017018119A (ja) 2017-01-26
US20170030895A1 (en) 2017-02-02
KR20140012119A (ko) 2014-01-29
CA2831003A1 (fr) 2012-10-26
CA2831003C (fr) 2021-06-01
EP2694961B2 (fr) 2022-01-05
EP3495816A1 (fr) 2019-06-12
AU2012246182B2 (en) 2016-12-01
JP6310973B2 (ja) 2018-04-11
US11168348B2 (en) 2021-11-09
RU2013149820A (ru) 2015-05-20
WO2012143647A1 (fr) 2012-10-26
US20140051097A1 (en) 2014-02-20
CA3077116A1 (fr) 2012-10-26
KR101918790B1 (ko) 2018-11-14

Similar Documents

Publication Publication Date Title
FR22C1038I2 (fr) Procédé de glycoconjugaison
CO6930312A2 (es) Método de notificación de aplicación
BR112014005087A2 (pt) método para detectar nucleossomas contendo nucleotídeos
BR112016012160A2 (pt) métodos para detecção de infecção de plasmodium
BR112014002562A2 (pt) método para monitoramento de fluidos
BR112014002252A2 (pt) métodos para a detecção de modificação de nucleotídeo
HK1216736A1 (zh) 移除軌道的疑似段的方法
BR112014011900A2 (pt) um método de purificação de anticorpo
CU24158B1 (es) Método de obtención de 1-kestosa
DE102012208877A8 (de) System zur Erfassung bewegter Objekte
BR112013028879A2 (pt) aparelho de filtragem
BR112014007958A2 (pt) método
BR112014001237A2 (pt) método
BR112014001851A2 (pt) método
BR112013027644A2 (pt) método de medição de conformação
BR112013030423A2 (pt) método para produção de biocoque
BR112014009795A2 (pt) método
BR112013025500A2 (pt) método para detectar contaminantes pró-inflamatórios de polímeros de glicose
DK2649029T3 (da) Fremgangsmåde til depolymerisering
BR112014016066A2 (pt) método para detectar micro-organismos salmonella
BR112013022820A2 (pt) método de tratamento
DE112012002431A5 (de) Selbstzentrierende Käfigmutter
FR2998290B1 (fr) Procede de potabilisation
BR112014003473A2 (pt) aparelhos indicadores de condição fisiológica particularizada
ES2388959B1 (es) Procedimiento y aparato de termolisis de polimeros de desecho.

Legal Events

Date Code Title Description
B06F Objections, documents and/or translations needed after an examination request according [chapter 6.6 patent gazette]
B06U Preliminary requirement: requests with searches performed by other patent offices: procedure suspended [chapter 6.21 patent gazette]
B09A Decision: intention to grant [chapter 9.1 patent gazette]
B16A Patent or certificate of addition of invention granted [chapter 16.1 patent gazette]

Free format text: PRAZO DE VALIDADE: 20 (VINTE) ANOS CONTADOS A PARTIR DE 06/04/2012, OBSERVADAS AS CONDICOES LEGAIS.

B16C Correction of notification of the grant [chapter 16.3 patent gazette]

Free format text: REF. RPI 2613 DE 02/02/2021 QUANTO AO INVENTOR.